Rheumatoid arthritis and Prothrombin level decreased

Summary:

Prothrombin level decreased is found among people with Rheumatoid arthritis, especially for people who are female, 60+ old.

The study analyzes which people have Prothrombin level decreased with Rheumatoid arthritis. It is created by eHealthMe based on reports of 13 people who have Rheumatoid arthritis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Rheumatoid arthritis?

Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints) is found to be associated with 1,676 drugs and 2,125 conditions by eHealthMe. Check the latest studies of Rheumatoid arthritis.

What is Prothrombin level decreased?

Prothrombin level decreased is found to be associated with 203 drugs and 465 conditions by eHealthMe. Check the latest studies of Prothrombin level decreased.



On Aug, 01, 2026

13 people who have Rheumatoid Arthritis and Prothrombin Level Decreased are studied.

Would you have Prothrombin level decreased when you have Rheumatoid arthritis?

Gender of people who have Rheumatoid Arthritis and experienced Prothrombin Level Decreased *:

  • female: 76.92 %
  • male: 23.08 %

Age of people who have Rheumatoid Arthritis and experienced Prothrombin Level Decreased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 8.33 %
  • 50-59: 0.0 %
  • 60+: 91.67 %

Common co-existing conditions for these people *:

  1. Implant Site Thrombosis: 3 people, 23.08%
  2. High Blood Pressure: 3 people, 23.08%
  3. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 15.38%
  4. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 15.38%
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 15.38%
  6. Cardiac Output Increased: 1 person, 7.69%

Common drugs taken by these people *:

  1. Remicade: 5 people, 38.46%
  2. Bactrim: 3 people, 23.08%
  3. Fenofibrate: 3 people, 23.08%
  4. Moxifloxacin Hydrochloride: 3 people, 23.08%
  5. Heparin: 3 people, 23.08%
  6. Coumadin: 2 people, 15.38%
  7. Folic Acid: 2 people, 15.38%
  8. Voltaren: 2 people, 15.38%
  9. Arava: 2 people, 15.38%
  10. Diovan: 2 people, 15.38%

Common symptoms for these people *:

  1. International Normalised Ratio Increased: 4 people, 30.77%
  2. Haematoma (collection of blood outside the blood vessels): 3 people, 23.08%
  3. White Blood Cell Count Decreased: 2 people, 15.38%
  4. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 15.38%
  5. Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 2 people, 15.38%
  6. Hepatitis B Surface Antigen Positive: 2 people, 15.38%
  7. Hepatitis B Dna Increased: 2 people, 15.38%
  8. Weakness: 2 people, 15.38%
  9. Haemorrhagic Diathesis (bleeding tendency): 2 people, 15.38%
  10. Dizziness: 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Prothrombin level decreased?

- Check whether Prothrombin level decreased is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Prothrombin level decreased:

All the conditions that are associated with Prothrombin level decreased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Prothrombin level decreased and Rheumatoid arthritis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: